Logotype for National Health Investors Inc

National Health Investors (NHI) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for National Health Investors Inc

Q3 2026 earnings summary

11 Nov, 2026

Executive summary

  • The July 1 NHC portfolio sale accelerated capital redeployment from skilled nursing toward private-pay senior housing and SHOP.

  • SHOP reached ~18% of total NOI including the October acquisition, up from 9% entering 2026; Q3 performance fell short of expectations amid occupancy and transition challenges.

  • Portfolio growth priorities are paired with a focus on operating execution, underperforming assets and disciplined investment.

Financial highlights

  • Q3 diluted EPS was $11.47 versus $0.69 YoY; net income attributable to common stockholders was $562.7M versus $32.8M, including a $541.6M NHC disposition gain.

  • Diluted NAREIT FFO was $1.12/share versus $1.09; diluted Normalized FFO was $1.12 versus $1.32. Q3 included $1.1M of abandoned-acquisition costs.

  • Q3 FAD was $57.1M versus $62.2M YoY; the payout ratio rose to 80.8% from 70.3%.

  • Lease revenue excluding specified non-cash items and reimbursements was $58.4M, down $12.9M YoY, mainly due to property disposals and properties moved to SHOP.

  • Q3 revenue was $113.5M versus $89.8M; resident fees and services rose to $47.7M from $21.2M as SHOP expanded.

Outlook and guidance

  • FY 2026 NAREIT and Normalized FFO guidance was revised to $4.68-$4.70/share; FAD guidance is $236.6M-$237.7M, with a $5M midpoint reduction.

  • Guidance assumes $190M of unidentified investments and existing commitments; total SHOP NOI is projected at $43.8M-$44.3M across 48 properties.

  • Same-store SHOP NOI growth guidance is 1%-3% for 15 properties in FY 2026 and 0%-1% for 26 properties in Q4.

  • Organic SHOP NOI growth objective remains high-single-digit to low-double-digit; Q4 holiday seasonality is expected to temper occupancy and near-term benefit.

  • Signed LOIs total $285.3M, including ~$190M expected to close in Q4; a further ~$400M pipeline is under evaluation, primarily SHOP.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from National Health Investors